Wellcome Trust Sanger Institute Archives

News and Trends 6 Dec 2017

CRISPR Does it Again! Gene Editing Tool Identifies a New Leukemia Target

Researchers from the Wellcome Trust Sanger Institute have reported that a new target for the treatment of leukemia has been found. A new drug target for acute myeloid leukemia (AML) has been identified that could open new avenues for the development of new treatments against the deadly disease. Researchers from the Wellcome Trust Sanger Institute have […]

December 6, 2017 - 3 minutesmins - By Alex Dale

News and Trends 24 Oct 2017

British Scientists Prove that it Takes Very Few Mutations to Cause Cancer

Researchers in the UK have analyzed over 7,500 tumors and estimate that a very low number of mutations is needed for cancer to develop. Researchers coming out of the prestigious Sanger Institute in Cambridge, UK has estimated that as few as 1 to 10 mutations are required to cause cancer. The study, published in Cell, was […]

October 24, 2017 - 2 minutesmins - By Alex Dale

Microbiome companies challenges opportunities

News and Trends 1 Jun 2017

Why Should we be Excited about the Emerging Microbiome Field?

A panel of experts at Microbiome Invest in London discussed the unlimited applications of the microbiome and how emerging companies may have a big impact on healthcare. During the past 10 years, the role of bacterial populations within our own organism has been studied, revealing a huge potential to develop new types of therapeutics. “The microbiome represents a […]

June 1, 2017 - 4 minutesmins - By External Contributor

News and Trends 30 Mar 2017

New Clues on How the Immune System Weakens with Age

By analyzing the responses of individual immune cells, a new study in Science provides new insights into the decline of the immune system with age. In a collaborative effort, researchers from the European Bioinformatics Institute (EMBL-EBI), University of Cambridge, the Wellcome Trust Sanger Institute and the Cancer Research UK–Cambridge Institute (CRUK-CI) have shed light on a […]

March 30, 2017 - 2 minutesmins - By Melanie De Almeida

Congenica Sapientia fundraising clinical genomics e1487935960201

More News! 27 Feb 2017

Fundraising in the UK will Support Rare Disease Diagnostics Worldwide

Congenica has raised £8M in its Series B financing round to sustain the international rollout of its clinical genome analysis platform Sapientia. Congenica is a genomic diagnostics company in Cambridge’s biotech cluster. Its genome analysis platform, Sapientia, takes on the challenge of interpreting the avalanche of genomic data becoming available in healthcare. The £8M (€9.5M) raised will sustain the […]

February 27, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

crispr platform protocol desktop genetics

News and Trends 6 Jan 2017

‘Packaged’ CRISPR Systems to Standardize novel Biomedical Research

There’s a growing appetite to refine and standardize CRISPR protocols, as its application expands into different areas of genomic research. The Wellcome Trust and Desktop Genomics have recent advances to make it more efficient and controllable. Outside of the high-stakes world of therapeutic CRISPR, which has enjoyed gambling-like investment and whose legal future is unfolding in court, this […]

January 6, 2017 - 3 minutesmins - By Denise Neves Gameiro

wellcome trust sanger cambridge Ebola epidemic quarantine global transmission

News and Trends 23 May 2016

Even after Quarantine, Ebola still transmitted by Breastfeeding and Sex

Researchers from University of Cambridge and the Wellcome Trust Sanger Institute have discovered that Ebola can still be transmitted through sex and breastfeeding after quarantine – causing ‘flare-ups’ even though the epidemic has ended. Without effective vaccines or treatments for Ebola infection, the 2014’s outbreak in West Africa was contained due to public health measures. These […]

May 23, 2016 - 3 minutesmins - By Denise Neves Gameiro

astrazeneca centre genomics research hli wellcome fimm

News and Trends 25 Apr 2016

AstraZeneca partners up with Genomics Elite for new Biobank

AstraZeneca has announced it will create a new Centre for Genomics Research in Cambridge (UK) – joining the Wellcome Sanger, a Craig Venter Biotech and a Finnish specialist Institute to do so. AstraZeneca is betting on genomics to transform drug discovery and support its R&D pipeline. The idea is to create a ‘biobank‘ with genome analysis, integrated with data from […]

April 25, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 3 Nov 2015

History of Biotech: 25 Years of The Human Genome Project

The birth of the Human Genome Project was now 25 years ago (woah!)…What was the HGP’s significance to biotech? What? The Human Genome Project (HGP) was an international effort with a primary goal; to sequence the entire genetic code of a whole organism (Humans…). It today remains the largest ever world collaborative project, which thrust the […]

November 3, 2015 - 5 minutesmins - By Marie Godar

News and Trends 1 Oct 2015

Artificially Intelligent ‘Betsy’ will analyse 100,000 genomes for UK Government

The “Berg Interrogative Biology” program from Boston (US) is a form of artificial intelligence the UK government has employed to work its Genome project. The platform will use a combination of systems biology techniques to analyse up to 100,000 genomes sourced from England’s National Health Service (NHS) for Genomics England (owned by the UK Department […]

October 1, 2015 - 2 minutesmins - By Dani Bancroft

Resources

Categories

The twelve hottest biotech companies in the Boston area

Biotech bankruptcies: what to expect in 2024 following a record year?

Approaches

Therapeutic areas

RNA editing set to take off: could it outperform gene editing?

Future of cancer treatment: what will therapy look like in 2034?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us